This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Astellas Pharma, Inc.
Drug Names(s): YM543
Description: YM543 is a SGLT2 inhibitor.
Deal Structure: YM543 is being codeveloped with Kotobuki Pharmaceuticals. Details of the partnership were not disclosed.
Partners: Kotobuki Pharmaceutical Co., Ltd.
Pink Sheet Weekly Trademark Review May 12, 2015
Pink Sheet Chart: Weekly Trademark Review
Additional information available to subscribers only: